Alpha-fetoprotein as a predictor of hepatocellular carcinoma recurrence following liver transplantation
Hepatoma Research · 10.10.2018 · 4 (10) · 63
DOI: 10.20517/2394-5079.2018.62 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hepatoma Research, online erschienen am 10.10.2018. Verfasst von Evangelia M. Fatourou und 2 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Gefördert von: King��s College Hospital Charity (Orpin Bequest and Kelly Group), European Association for the Study of Liver.
Abstract (Originalsprache)
Hepatoma Research is an open access journal and focuses on all topics related to hepatoma. The following articles are especially welcome: pathogenesis, clinical examination and early diagnosis of hepatoma, complications of hepatoma, and their preventions and treatments, etc.
Förderung
- King��s College Hospital Charity (Orpin Bequest and Kelly Group)
- European Association for the Study of Liver
Zitieren
APA
Fatourou, E. M., Suddle, A. R., & Heneghan, M. A. (2018). Alpha-fetoprotein as a predictor of hepatocellular carcinoma recurrence following liver transplantation. Hepatoma Research, 4(10), 63. https://doi.org/10.20517/2394-5079.2018.62
Vancouver
Fatourou EM, Suddle AR, Heneghan MA. Alpha-fetoprotein as a predictor of hepatocellular carcinoma recurrence following liver transplantation. Hepatoma Research. 2018;4(10):63. doi:10.20517/2394-5079.2018.62
BibTeX
@article{Fatourou2018,
author = {Fatourou, Evangelia M. and Suddle, Abid R. and Heneghan, Michael A.},
title = {Alpha-fetoprotein as a predictor of hepatocellular carcinoma recurrence following liver transplantation},
journal = {Hepatoma Research},
year = {2018},
volume = {4},
number = {10},
pages = {63},
doi = {10.20517/2394-5079.2018.62}
}
EUVIMED